TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings

Table 4

Thrombosis in the whole cohort stratified by TET2 mutational status.

	TET2-positive MPN (𝑛=7)	TET2-negative MPN (𝑛=90)	𝑃 value
Arterial thrombosis
Ischemic heart syndrome	1/7	13/90	ns
Ischemic stroke	0/7	4/90
Venous thrombosis
DVT	2/7	2/90
Portal thrombosis	0/7	3/90	ns
BCS	0/7	1/90